Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
interferon alpha-2b (Intron-A) (1 trial)
lidocaine (xylocaine) (1 trial)
orlistat (xenical) (1 trial)
protein rich plasma (1 trial)
ribavirin (virazole) (1 trial)
triamcinolone (kenalog) (1 trial)
mogroside (1 trial)
autologous mesenchymal cells (1 trial)
pioglitazone (actos) (1 trial)
propofol (diprivan) (1 trial)
Fatty Liver (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Trials (7 total)
Trial APIs (10 total)